Related Experiment Video

Updated: Aug 13, 2026

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Perioperative respiratory complications caused by cystic lung malformation in Proteus syndrome

Masaki Nakane1, Mikako Sato, Hisashi Hattori

  • 1Department of Anesthesiology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan.

Journal of Anesthesia
|January 20, 2006
PubMed

Insights

Patients with Proteus syndrome undergoing spinal surgery may face respiratory issues due to cystic lung malformations. These malformations are a key risk factor for perioperative respiratory failure, more so than reduced lung function.

Area of Science:

  • Medicine
  • Genetics
  • Pulmonology

Background:

  • Proteus syndrome is a rare congenital disorder characterized by overgrowth of tissues.
  • Severe kyphoscoliosis and cystic lung malformations are known complications.
  • Spinal fusion surgery is often required for severe spinal deformities.

Observation:

  • A 7-year-old girl with Proteus syndrome and cystic lung malformation experienced respiratory complications during and after spinal fusion.
  • The patient had significant kyphoscoliosis requiring posterior spinal fusion under general anesthesia.
  • Cystic lung malformation was predominantly noted in the right lung.

Findings:

  • Perioperative respiratory complications, including low oxygenation and ventilation-perfusion mismatch, were observed.
  • Postoperative respiratory failure was attributed to increased bronchial secretions and bacterial pneumonia.
  • Cystic lung malformation was identified as a significant predictive factor for perioperative respiratory failure.

Implications:

  • Cystic lung malformation should be considered a critical risk factor for perioperative respiratory complications in Proteus syndrome patients.
  • Enhanced respiratory monitoring and management strategies are crucial for these patients.
  • Further research into the pulmonary manifestations of Proteus syndrome is warranted.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: